Strata Critical Medical Reports Q2 2026 Financial Results

What Happened
On August 4, 2026, Strata Critical Medical, Inc. announced its financial results for the second quarter ended June 30, 2026 by issuing a press release. The company filed a Current Report on Form 8-K (Item 2.02) to furnish that press release (Exhibit 99.1). The Form 8-K was signed by William A. Heyburn, Co‑Chief Executive Officer and Chief Financial Officer.

Key Details

• Form 8-K filed and furnished on August 4, 2026 (Item 2.02: Results of Operations and Financial Condition).
• The results cover the quarter ended June 30, 2026.
• Press release is attached as Exhibit 99.1; a Cover Page Interactive Data File (Exhibit 104) is included.
• Signed by William A. Heyburn (Co‑CEO & CFO); no management changes were disclosed in this filing.

Why It Matters
This filing notifies investors that Strata has publicly released its Q2 earnings and related quarterly results. The press release will contain the company’s reported revenue, earnings, cash and other key metrics that can affect the stock and near‑term investor outlook. Retail investors should review Exhibit 99.1 (the press release) on the SEC’s EDGAR site or Strata’s investor relations page to see the specific financial figures and any commentary about guidance or business trends.